Elk Creek Partners’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-1,089
| Closed | -$200K | – | 132 |
|
|
2019
Q1 | $200K | Sell |
1,089
-448
| -29% | -$82.3K | 0.01% | 131 |
|
|
2018
Q4 | $255K | Sell |
1,537
-2,253
| -59% | -$374K | 0.02% | 128 |
|
|
2018
Q3 | $730K | Hold |
3,790
| – | – | 0.04% | 125 |
|
|
2018
Q2 | $644K | Sell |
3,790
-182
| -5% | -$30.9K | 0.04% | 128 |
|
|
2018
Q1 | $647K | Buy |
3,972
+580
| +17% | +$94.5K | 0.04% | 131 |
|
|
2017
Q4 | $508K | Hold |
3,392
| – | – | 0.03% | 135 |
|
|
2017
Q3 | $516K | Buy |
3,392
+272
| +9% | +$41.4K | 0.03% | 133 |
|
|
2017
Q2 | $402K | Hold |
3,120
| – | – | 0.03% | 136 |
|
|
2017
Q1 | $341K | Buy |
3,120
+10
| +0.3% | +$1.09K | 0.02% | 139 |
|
|
2016
Q4 | $229K | Sell |
3,110
-1,247
| -29% | -$91.8K | 0.02% | 147 |
|
|
2016
Q3 | $380K | Sell |
4,357
-405
| -9% | -$35.3K | 0.03% | 133 |
|
|
2016
Q2 | $410K | Sell |
4,762
-6,577
| -58% | -$566K | 0.03% | 130 |
|
|
2016
Q1 | $901K | Sell |
11,339
-850
| -7% | -$67.5K | 0.07% | 130 |
|
|
2015
Q4 | $1.53M | Sell |
12,189
-268
| -2% | -$33.7K | 0.11% | 124 |
|
|
2015
Q3 | $1.3M | Buy |
12,457
+6,251
| +101% | +$651K | 0.1% | 130 |
|
|
2015
Q2 | $766K | Sell |
6,206
-5,738
| -48% | -$708K | 0.07% | 142 |
|
|
2015
Q1 | $1.41M | Hold |
11,944
| – | – | 0.15% | 143 |
|
|
2014
Q4 | $1.42M | Buy |
+11,944
| New | +$1.42M | 0.18% | 139 |
|